Analyzing and utilizing NIH award data for your strategic advantage

1. Analyzing and utilizing NIH award data for your strategic advantage Perry Kirkham, Ph.D. Office of the Vice President for Research E-mail: pkirkham@purdue.edu Phone: 63645

2. NIH Workshop topics and dates 9/20 STEW 202 11/2 STEW 310 2/16 STEW 202 NIH Overview/IC missions and funding strategies NIH submission strategies, grantsmanship, and review process Analyzing and utilizing NIH award data for your strategic advantage

3. Questions and answers from previous workshops Summary statements Differential IC missions Review meetings Specific aims relative to particular mechanisms R21 future Use of the OVPR resources

4. NIH update NCRR ---> NCATS ($639M) New initiatives: Rescuing and repurposing drugs Designing a tissue chip for drug screening Identifying and validating drug targets Programs: Bridging interventional development gaps CTSA Cures Acceleration Network ($50M) FDA-NIH regulatory science Office of Rare Diseases Research Components of the Molecular Libraries Therapeutics for Rare and Neglected Diseases http://rarediseases.info.nih.gov/

5. NIH update NIDA/NIAAA ---> National Institute of Substance Use and Addiction Disorders FY 2014 Strategic planning underway Developing a compendium of the pharmacokinetic and pharmacodynamic interactions between alcohol and the therapeutics used to treat general medical and psychiatric conditions (e.g., hypertension, diabetes, epilepsy, depression); Developing strategies to enhance  stakeholder interest in developing medications to treat various addictions, including nicotine and alcohol; Targeting efforts to prevent substance abuse in adolescents and young-adults; Understanding the implications of policy changes on substance use patterns and trajectories, especially in youth; Furthering knowledge of tobacco use and addiction, including co-morbidity with other addiction and psychiatric disorders

6. NIH update • FY13 Budget Request ($30.7B) • 9414 new and competing Research project grants (increase of 672 over FY12) • Discontinue outyear inflationary allowances • Reduce non-competing continuation grants by 1% below FY12 levels • Negotiate competing grants to maintain average award size • $80M in new research money for Alzheimer’s diseases

7. What information can you get from NIH award data? How do I determine where to send my proposal? What type of awards have been made in response to a PAR or RFA? What awards have been made from a given study section? Which program officer to contact to float ideas about a proposal? What ideas or fields are funded by the NIH in general and an institute in specific?

9. NIH

10. How do I determine where to send my proposal? Current and trending IC success rates http://report.nih.gov/success_rates/index.aspx Grants: Applications, awards, success rates and total funding by IC, mechanism, activity code, and funding source Research project grants: success rates by type, activity, and IC (FY 2001 – 2011)

11. What type of awards have been made in response to a PAR? The active announcement may be a reissue of a former announcement

14. Alzheimer’s

15. Anthropology

16. What awards have been made from a given study section?

17. Which program officer to contact to float ideas about a proposal?

20. What ideas or fields are funded by the NIH in general and an institute in specific? Council reports Director’s budget requests RePORTER data Program officer

21. Aging

23. Aging

24. Agricultural

25. Mathematical Modeling

26. Neurodegeneration

27. Nanotechnology